(From left to right: Stephen Burns, Medline Executive Vice President of Sales; Phong Tran, Alfa Wassermann Director of Business Development; Diana LeFebvre, Medline Group President of Lab & Diagnostics; Mark Gnagy, Alfa Wassermann Vice President of Sales)
Alfa Wassermann Diagnostic Technologies receives 2018 Sales Collaboration Award
Congratulations to Alfa Wassermann Diagnostic Technologies for receiving the 2018 Sales Collaboration Award at the Medline Industries, Inc., National Sales Meeting for Specialty Sales in Orlando, Florida on April 10, 2019. Presented by Medline Group President of Lab & Diagnostics, Diana LeFebvre, Alfa Wassermann received the award for their efforts in working with Medline to grow their lab business in the Education and Research market.
Brian Vierra
Midmark names Brian Vierra as Director of Sales, Medical
Midmark Corp., announced Brian Vierra was promoted to director of sales, medical. In this leadership position, Vierra will lead, manage and develop the Midmark medical salesforce through his connected team of region directors effective July 1, 2019. Vierra has been with Midmark for 14 years, and in that time has held roles in the medical division as a sales representative for the Pittsburgh territory and region director for three different regions. Most recently, he has held the position of field sales leader for the past eight years.
Braun announces $1B investment to alleviate IV fluid shortages in the U.S.
Braun Medical Inc (Bethlehem, PA) announced Solutions for Life, a $1 billion investment in new and enhanced IV therapy manufacturing facilities to help ensure a reliable and consistent supply of vital IV fluids that American healthcare providers need every day. The investments include a new state-of-the-art manufacturing facility in Daytona Beach, FL, and modernizations to existing facilities in Irvine, CA, and Allentown, PA. B. Braun obtained FDA approval of IV fluids from European facilities should the need arise in the future. Several years ago, B. Braun prioritized and began investments to support long-term and ongoing supply capacity.